News & Events :: Can-Fite BioPharma Ltd. (CANF)

Recent News View All News

Mar 24, 2025 9:00am EDT

Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA-Approved Protocol

Mar 20, 2025 9:45am EDT

Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market

Recent Events View IR Calendar

Feb 25, 2025 4:15 pm EDT

RedChip Investor Webinar with Can-Fite Biopharma

Feb 10, 2025 3:45 pm EDT

BIO CEO & Investor Conference 2025

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings